Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphoma

Diffuse large B-cell lymphoma (DLBCL) and osteoporotic fracture are both more common in older patients. Exposure to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone) is likely to increase the risk of fracture, but evidence is lacking to define fracture incidence in thi...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Blood Adv
Auteurs principaux: Booth, Stephen, Plaschkes, Hannah, Kirkwood, Amy A., Gibb, Adam, Horgan, Patrick, Higham, Claire, Oladipo, Joanna M., Browning, Joe, Khan, Usman, Tseu, Bing, Chen, Lucia, Willan, John, Wolf, Julia, Gunawan, Arief, Fields, Paul, Ebsworth, Tim, Lown, Robert, Gordon-Walker, Dominic, Shah, Nimish, Linton, Kim M., Collins, Graham P., Kothari, Jaimal, Hildyard, Catherine, Eyre, Toby A.
Format: Artigo
Langue:Inglês
Publié: American Society of Hematology 2020
Sujets:
Lymphoid Neoplasia
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7509870/
https://ncbi.nlm.nih.gov/pubmed/32915975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002553
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires